Vanguard Portfolio Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Buy
1,651,293
+205,314
+14% +$2.03M ﹤0.01% 2052
2026
Q1
$14.1M Buy
+1,445,979
New +$13.3M ﹤0.01% 2015

Other funds holding PRTA

Vanguard Portfolio Management's PRTA Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Prothena Corp (PRTA) stake by 14% in Q2 2026, buying an estimated $2.03M and bringing the position to 1,651,293 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

Vanguard Portfolio Management first reported a position in PRTA in Q1 2026 and has held it in 2 quarters since. 186 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Vanguard Portfolio Management held 1,651,293 shares of Prothena Corp worth $16.2M as of Q2 2026.
  • Vanguard Portfolio Management bought 205,314 Prothena Corp shares in Q2 2026, an estimated $2.03M.
  • Prothena Corp made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2052 holding.
  • Vanguard Portfolio Management first reported a position in Prothena Corp in Q1 2026 and has held it in 2 quarters since.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.